ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,315.60
0.44%
Dow Jones
38,386.09
0.38%
Brent Oil
87.035
-0.29%
Bitcoin
64,561.21
1.13%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Rani Therapeutics Holdings Inc (RANI) Quote

Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc (RANI)

NASDAQ
6.70
0.02
(0.30%)
Closed April 29 4:00PM
Delayed by 15 minutes
6.70
0.00
(0.00%)
After Hours: 7:27PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
6.70
Bid
6.50
Ask
6.89
Volume
60,421
6.51 Day's Range 6.70
1.82 52 Week Range 8.75
Market Cap
334.977M
Previous Close
6.68
Open
6.61
Last Trade
47
@
6.7
Last Trade Time
Financial Volume
$ 400,047
VWAP
6.621
Average Volume (3m)
135,940
Shares Outstanding
49,996,508
Dividend Yield
-
PE Ratio
-9.86
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-33.97M

About Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ranitherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $6.68. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

Rani Therapeutics currently has 49,996,508 shares outstanding. The market capitalization of Rani Therapeutics is $334.98 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -9.86.

RANI Latest News

More News

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

- Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Announced Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1...

March 20 2024
GlobeNewswire Inc.

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

March 15 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 05 2024
Edgar (US Regulatory)

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

- RT-111 achieved high bioavailability in humans - - RT-111 was well-tolerated, with no serious adverse events - - Celltrion has right of first negotiation to acquire worldwide rights to RT-111...

February 05 2024
GlobeNewswire Inc.

Form 8-K - Current report

December 19 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 19 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 19 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 19 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.3-4.2857142857177.656.241306716.71006511CS
43.57114.0575079873.138.753.0452394536.27274702CS
123.1990.88319088323.518.752.851359405.17871233CS
264.71236.6834170851.998.751.821143874.19700861CS
522.0945.33622559654.618.751.82851534.01326441CS
156-4.56-40.497335701611.2636.271.828452011.39412747CS
260-4.56-40.497335701611.2636.271.828452011.39412747CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSLRComplete Solaria Inc
$ 0.7303
(91.73%)
25.79M
MULNMullen Automotive Inc
$ 5.73
(81.33%)
72.12M
DCPHDeciphera Pharmaceuticals Inc
$ 25.28
(72.56%)
50.72M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
LICNLichen China Limited
$ 2.03
(48.18%)
3.96M
CLVRClever Leaves Holdings Inc
$ 1.62
(-60.58%)
768.37k
ADXNAddex Therapeutics Ltd
$ 7.68
(-52.30%)
160.84k
TSDDGraniteShares ETF Trust GraniteShares
$ 17.1879
(-30.97%)
1.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 27.23
(-30.66%)
7.72M
MFImF International Ltd
$ 1.665
(-28.54%)
3.55M
TSLATesla Inc
$ 194.05
(15.31%)
243.77M
SINTSiNtx Technologies Inc
$ 0.053477
(32.37%)
174.36M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
SOFISoFi Technologies Inc
$ 7.045
(-10.48%)
149.62M
SQQQProShares UltraPro Short QQQ
$ 11.31
(-1.05%)
97.67M

RANI Discussion

View Posts
PonkenPlonken PonkenPlonken 1 week ago
wants sooo much more
👍️0
PonkenPlonken PonkenPlonken 2 weeks ago
shake shake the tree
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...HERE COMES 9.00...LOL
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...8 DOLLA FLOOR BEING BUILT
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI 8 DOLLA...FORTUNE COOKIE WAS RIGHT....LMAO
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...LETS SEE 8 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
SOMEONE WITH BRAINS AROUND HERE
👍️ 1
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...GAPPING TO 7.50...LMAO...WHAT A CALL FROM THE HOUSE OF TREND
👍️0
PonkenPlonken PonkenPlonken 2 weeks ago
$RANI can clear worries about GLP adm.
No sellers in consecutive sessions.
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
ITS RAINING AGAIN WITH RANI...IS TIM ON THIS ONE?!!
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...LET THEM CHASE THE ALGO FABRICATIONS WHILE WE WATCH RANI TREND TO 7.00
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...HERE COMES 7.00
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...BREAKING NEW HIGH
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...BREAKING 6.00...BIO BEAST!!!
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...ITS RAINING AGAIN
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI....BIO MONSTER
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...THIN AS THIN...ARCA BID
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
RANI...NEXT BIO BEAST READY TO BEAST
👍️0

Your Recent History

NASDAQ
RANI
Rani Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved